In this study, we found that IGF2BP2 could promote the EMT program to increase the mobility and invasiveness of HNSCC cells in vitro, which is in accordance with other studies [52, 56]. The gene discussed is IGF2BP2; the disease is head and neck squamous cell carcinoma.